饮食预防肝癌的作用研究进展

doi:10.3969/j.issn.1672-5069.2014.05.005

实用肝脏病杂志 ›› 2014, Vol. 17 ›› Issue (5): 463-465.doi: 10.3969/j.issn.1672-5069.2014.05.005

饮食预防肝癌的作用研究进展

王阁, 蒋梅

400042 重庆市第三军医大学大坪医院肿瘤中心

收稿日期:2014-06-15 出版日期:2014-10-31 发布日期:2016-04-11
作者简介:王阁,男,45岁,医学博士,主任医师,教授,博士生导师。重庆市中西医结合学会肿瘤放射治疗专业委员会主任委员,《中华肝脏病杂志》和《临床肝胆病杂志》等5种杂志编委。E-mail：Wangge70@hot-mail.com

Consumption of healthy foods and beverages reduces risk for hepatocellular carcinoma

Wang Ge, Jiang Mei

Cancer Center,Daping Hospital,Third Military Medical University,Chong Qing 400042

Received:2014-06-15 Online:2014-10-31 Published:2016-04-11

摘要/Abstract

关键词: 肝癌, 饮食, 饮料, 预防

Key words: Hepatocellular carcinoma, Diet, Beverages, Prevention

王阁, 蒋梅. 饮食预防肝癌的作用研究进展[J]. 实用肝脏病杂志, 2014, 17(5): 463-465.

Wang Ge, Jiang Mei. Consumption of healthy foods and beverages reduces risk for hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 463-465.

[1] El-Serag HB. Hepatocellular carcinoma. N Engl J Med, 2011,365（12）:1118-1127.
[2] Cross AJ,Freedman ND,Ren J. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol,2011,106（3）:432-442.
[3] Larsson SC,Wolk A. Red and processed meat consumption and risk of pancreatic cancer:meta-analysis of prospective studies. Br J Cancer,2012,106（3）:603-607.
[4] Yang WS,Wong MY,Vogtmann E. Meat consumption and risk of lung cancer:evidence from observational studies. Ann Oncol,2012,23（12）:3163-3170.
[5] Kanazir M,Boricic I,Delic D. Risk factors for hepatocellular carcinoma:a case-control study in Belgrade （Serbia）. Tumori, 2010,96（6）:911-917.
[6] Abid Z,Cross AJ,Sinha R. Meat,dairy,and cancer. Am J Clin Nutr,doi:10.3945/ajcn. 113.071597.
[7] Tasevska N,Sinha R. A prospective study of meat, cooking methods,meat mutagens,heme iron,and lung cancer risks. Am J Clin Nutr,2009,89:1884-1894.
[8] Freedman ND,Cross AJ,McGlynn KA. Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIHAARP cohort. J Natl Cancer Inst,2010,102（17）:1354-1365.
[9] Fedirko V,Trichopolou A,Bamia C. Consumption of fish and meats and risk of hepatocellular carcinoma:the European Prospective Investigation into Cancer and Nutrition （EPIC）. Ann Oncol,2013,24（8）:2166-2173.
[10] Luo J,Yang Y. Systematic review with meta-analysis:meat consumption and the risk of hepatocellular carcinoma. Aliment Pharmacol Ther,2014,39（9）:913-922.
[11] Fauser JK,Prisciandaro LD. Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer Biol Ther,2011,11（8）:724-731.
[12] Huang C,Ding G,Gu C. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1ato promote hepatocellular carcinoma invasiveness. Clin Cancer Res,2012,18（11）:3042-3053.
[13] Hou Y,Zhuang W,Hu W. Consumption of large amounts of allium vegetables reduces risk for gastric cancer in a meta-analysis. Gastroenterology,2011,141（1）:80-89.
[14] Kurahashi N,Inoue M. JPHC Study Group:Vegetable,fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma:a prospective cohort study in Japan. Br J Cancer,2009,100（1）:181-184.
[15] Huang CS,Liao JW,Hu ML. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic mice. J Nutr,2008,138（3）:538-543.
[16] Nishion H. Phyotchemicals in hepatocellular cancer prevention.Nutr Cancer,2009,61（6）:789-791.
[17] Piljac-Zegarac J,Samec D,Piljac A. Antioxidant properties of extracts of wild medicinal mushroom species from Croatia. Int J Med Mushrooms,2011,13（3）:257-263.
[18] Shah SK,Peter A. An evidence-based review of a lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient. JPEN,2011,35（4）:449-458.
[19] Zhang W,Xiang YB. Vegetable-based dietary pattern and liver cancer risk:Results from the Shanghai Women,s and Men,s Health Studies. Cancer Sci,2013,104（10）:1353-1361.
[20] Bishayee A,Politis T,Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev,2010,36（1）:43-53.
[21] Howells LM,Berry DP,Elliott PJ. Phase I randomized, double-blind pilot study of micronized resveratrol（SRT501） in patients with hepatic metastases-safety,pharmacokinetics,and pharmacodynamics.Cancer Prev Res （Phila）,2011,4（9）:1419-1425.
[22] Liu Y,Liu M,Li B. Fresh raspberry phytochemical extract inhibits hepatic lesion in a Wistar rat model. Nutr Metab （Lond）,2010,7:84.
[23] Morii H,Kuboyama A,Nakashima T. Effects of instant coffee consumption on oxidative DNA damage,DNA repair,and redox system in mouse liver. J Food Sci,2009,74（6）:H155-161.
[24] Bravi F,Bosetti C,Tavani A. Coffee drinking and hepatocellular carcinoma risk:a meta-analysis. Hepatology,2007,46（2）:430-435.
[25] Johnson S,Koh WP,Wang R. Coffee consumption and reduced risk of hepatocellular carcinoma:findings from the Singapore Chinese Health Study. Cancer Causes Control,2011,22（3）:503-510.
[26] Masterjohn C,Bruno RS. The therapeutic potential of green tea in non-alcoholic fatty liver disease. Nutr Rev,2012,70（1）:41-56.
[27] Li Y,Chang SC,Goldstein BY. Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol,2011,35（4）:362-368.
[28] Fon Sing M,Yang WS,Gao S. Epidemiological studies of the association between tea drinking and primary liver cancer:a meta-analysis. Eur J Cancer Prev,2011,20（3）:157-165.

饮食预防肝癌的作用研究进展

Consumption of healthy foods and beverages reduces risk for hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	邢昊, 韩骏, 杨田. 应用血清PIVKA-II诊断肝细胞癌研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 934-937.
[2]	刘杏, 赵树立, 张殿隆. 七氟烷吸入时机对肝脏部分切除术患者肝脏缺血再灌注损伤的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 728-731.
[3]	裴颖, 黄峰, 殷宏振, 郭化磊. 去甲斑蝥酸钠对肝癌异位移植瘤小鼠肠道微生态的影响初探*[J]. 实用肝脏病杂志, 2019, 22(4): 486-489.
[4]	戴青云, 王润东, 荚卫东. 术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*[J]. 实用肝脏病杂志, 2019, 22(4): 561-564.
[5]	崔发强, 李涛, 王铮, 陈青. 原发性肝癌患者外周血KRAS基因水平及其对西妥昔单克隆抗体治疗疗效的影响[J]. 实用肝脏病杂志, 2019, 22(4): 565-568.
[6]	刘彦君, 李光明. 肝硬化并发门静脉血栓防治研究进展[J]. 实用肝脏病杂志, 2019, 22(4): 605-608.
[7]	赵晓光, 史玉洁. 应用还原型谷胱甘肽预防处理接受TACE治疗的中晚期原发性肝癌患者对肝功能的影响[J]. 实用肝脏病杂志, 2019, 22(3): 425-428.
[8]	李克田,沈明格,王凤荣,胡春荣,曹玉杰,芦鹏. 血糖水平对原发性肝癌患者¹⁸F-FDG摄取和PET/CT检查图像质量的影响研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 256-259.
[9]	张帮健,魏寿存,杨小燕. 右美托咪啶联合丙泊酚麻醉对肝癌切除术患者围手术期血清细胞因子和术后苏醒质量的影响 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 264-267.
[10]	王荣明, 江建宁. HBV感染母亲新生儿预防接种与母乳喂养^*[J]. 实用肝脏病杂志, 2019, 22(1): 6-8.
[11]	李芳, 邹桂舟, 叶珺, 郜玉峰. 不同HBV感染转归人群外周血PD-1拷贝数分布研究^*[J]. 实用肝脏病杂志, 2019, 22(1): 37-40.
[12]	王翠晓, 高静. 血清高尔基蛋白73、甲胎蛋白异质体3、甲胎蛋白和α-L-岩藻糖苷酶水平诊断原发性肝癌的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(1): 113-116.
[13]	陈向, 汪宝林, 吴琛, 唐劲草, 张弛, 褚朝顺. 动脉灌注化疗栓塞联合放射粒子植入治疗原发性肝癌患者疗效及其对肝组织TRF1和TRF2表达的影响^*[J]. 实用肝脏病杂志, 2019, 22(1): 121-124.
[14]	闫书鸣, 王建国, 李泽信, 游焜, 王亮, 郭鹏威. 门冬氨酸鸟氨酸治疗肝癌切除术患者对肝脏缺血再灌注损伤的保护作用研究^*[J]. 实用肝脏病杂志, 2018, 21(6): 932-935.
[15]	汪华, 赵亚宁. 索拉菲尼治疗进展期原发性肝癌患者有效性及安全性研究^*[J]. 实用肝脏病杂志, 2018, 21(6): 936-939.